ORC6 and cancer: Our data showed that ORC6 expression level was significantly related to different immune subtypes in 15 types of cancers (e.g., BRCA, LIHC, and PRAD); these data may partially explain why ORC6 plays different roles in the prognosis and immunotherapy response of diverse cancers.